This trial is active, not recruiting.

Conditions postoperative complications, randomized, prevention, smoking cessation
Treatment smoking cessation
Sponsor Karolinska Institutet
Start date January 2004
End date January 2008
Trial size 584 participants
Trial identifier NCT00533000, 03-214


The primary aim of this study is to evaluate the effect of preoperative smoking cessation on postoperative complications among patients undergoing surgery. Secondary aims are to evaluate effect on wound complications, short and long term effects including abstinence rate, pain, quality of life and effects on the immune system.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking single blind (outcomes assessor)
Primary purpose prevention
Smoking cessation
smoking cessation
Weekly smoking cessation by professional counseling and nicotine substitute on request
(No Intervention)

Primary Outcomes

Frequency of any postoperative complication
time frame: 1 month

Secondary Outcomes

wound complication rate, smoking cessation rates, level of postoperative pain, quality of life, thioredoxin reductase, Il-1, Il-6, TNFa
time frame: 1-12 months

Eligibility Criteria

Male or female participants from 18 years up to 79 years old.

Inclusion Criteria: - Active, daily tobacco smokers (> 2 cigarettes daily for at least one year prior to inclusion), 18-79 years old at the time of randomisation. - Proficiency in the Swedish language. - Oral and written consent. - Scheduled for primary inguinal hernia repair or other umbilical hernia repair or laparoscopic cholecystectomy - Scheduled for hip- or knee replacement Exclusion Criteria: - - Active drug abuse or severe mental illness prohibiting compliance with the study protocol. - Pregnancy. - Residence outside the county of Stockholm.

Additional Information

Official title Short Term Perioperative Smoking Cessation and the Effect on Postoperative Complications. A Randomized Clinical Trial.
Principal investigator Johanna Adami, MD
Description Tobacco smokers suffers from postoperative complications after surgery more extensively than non-smokers. Our primary aim is to study if smoking cessation four weeks prior to elective surgery decreases the number of postoperative complications. Secondary aims is to analyse if smoking cessation four weeks prior to elective surgery decreases wound complications, analyse the effect on abstinence rate, effect on postoperative pain, quality of life and if smoking cessation normalises; the immunological response to surgery. The study is randomised, prospective, multicenter-based trial. Daily smokers are randomised to 1. Control group (standard care) or 2. smoking cessation. Patients randomised to smoking cessation will undergo professional motivational counselling and will receive free nicotine substitution. The study will include elective cases that are scheduled for surgery. Cessation starts 3-5 weeks prior to surgery. All patients are prospectively followed up for four weeks concerning post-operative complications and for one year concerning other outcomes. Outcome (complications) is registered by a blind observer. Analyses will be performed by intention to treat. The intervention group is compared with the control group and an adjustment for possible confounders will be done. There will also be an analysis in the subgroups depending on which surgical procedure was performed.Secondary analyses will be by protocol
Trial information was received from ClinicalTrials.gov and was last updated in June 2008.
Information provided to ClinicalTrials.gov by Karolinska Institutet.